Table 3.
Coordinates (hg19) of critical regions of 12 SCZ‐associated CNVs
| Chr* | Start | End | Location | Type | Likely candidate gene(s) | Criteria for defining this CNV b |
|---|---|---|---|---|---|---|
| chr1 | 146,527,987 | 147,394,444 | 1q21.1 | Deletion | . | Size >50% of critical region |
| chr1 | 146,527,987 | 147,394,444 | 1q21.1 | Duplication | . | Size >50% of critical region |
| chr2 | 50,145,643 | 51,259,674 | 2p16.3 | Deletion | NRXN1 | Deletion of at least one exon (NM_004801) |
| chr3 | 195,720,167 | 197,354,826 | 3q29 | Deletion | DLG1 | Size >50% of critical region |
| chr7 c | 72,744,915 | 74,142,892 | 7q11.23 | Duplication | STX1A | Size >50% of critical region |
| chr15 | 22,805,313 | 23,094,530 | 15q11.2 | Deletion | CYFIP1 | Size >50% of critical region |
| chr15** c | 23,561,268 | 28,390,339 | 15q11.2‐q13.1 | Duplication | UBE3A and GABA receptor gene cluster | Full critical region |
| chr15 | 31,080,645 | 32,462,776 | 15q13.3 | Deletion | . | Size >50% of critical region |
| chr16 | 15,511,655 | 16,293,689 | 16p13.11 | Duplication | MYH11 | Size >50% of critical region |
| chr16 | 21,950,135 | 22,431,889 | 16p12.1 | Deletion | UQCRC2 | Size >50% of critical region |
| chr16 | 29,650,840 | 30,200,773 | 16p11.2 | Duplication | ALDOA, CORO1A, MAPK3, TAOK2 | Size >50% of critical region |
| chr22 c | 19,037,332 | 21,466,726 | 22q11.2 | Deletion | PI4KA, SEPT5 | Size >50% of critical region |
Chr = chromosome.
aCoordinates taken from Supporting Information of Kendall et al., 2016 (except for **). For analyses, the liftOver tool was used to map from hg19 to hg18 coordinates, specifying minimum ratio of bases that must remap as 0.95.
bSee Supporting Information Table S4 of Kendall et al. (2016).
cCNVs not observed in this study population.